Rice University's Han Xiao has used his AI-supported Sequence Display technology to expand the targeting abilities of ...

A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell ...

Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and nerve damage.

A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem ...

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

A personalized CRISPR treatment for a critically ill baby shows how editing, RNA manufacturing, and delivery are converging into faster, more reproducible therapeutic workflows. For most ...

Despite this advance, conventional CRISPR-Cas9 systems may introduce potentially harmful DNA breaks and cannot easily be ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Crispr Therapeutics (CRSP) is downgraded to "Hold" as current valuation already reflects optimism for CTX310 Phase I results and pipeline progress. Intellia Therapeutics (NTLA) maintains a "Buy" ...

Emerging gene-editing platforms are demonstrating that disease-causing mutations, aberrant gene expression, and even large-scale DNA insertions can be corrected without relying on error-prone DNA ...

A preliminary study of 52,330 Israeli women found similar rates of heart attack, stroke, blood clots and early death among hormone therapy users and nonusers, though it cannot prove safety. Older ...